GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Life Science REIT PLC (CHIX:LABSl) » Definitions » Debt-to-Revenue

Life Science REIT (CHIX:LABSL) Debt-to-Revenue : 16.87 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Life Science REIT Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Life Science REIT's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was £0.00 Mil. Life Science REIT's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was £122.24 Mil. Life Science REIT's annualized Revenue for the quarter that ended in Dec. 2024 was £7.24 Mil. Life Science REIT's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 16.87.


Life Science REIT Debt-to-Revenue Historical Data

The historical data trend for Life Science REIT's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Life Science REIT Debt-to-Revenue Chart

Life Science REIT Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
- N/A N/A N/A

Life Science REIT Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial N/A 4.44 N/A N/A 16.87

Competitive Comparison of Life Science REIT's Debt-to-Revenue

For the REIT - Healthcare Facilities subindustry, Life Science REIT's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Life Science REIT's Debt-to-Revenue Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Life Science REIT's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Life Science REIT's Debt-to-Revenue falls into.


;
;

Life Science REIT Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Life Science REIT's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 122.238) / -5.628
=-21.72

Life Science REIT's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 122.238) / 7.244
=16.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2024) Revenue data.


Life Science REIT Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Life Science REIT's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Life Science REIT Business Description

Traded in Other Exchanges
Address
51 Clarendon Road, First Floor Radius House, Watford, Hertfordshire, GBR, WD17 1HP
Life Science REIT PLC is the first London-listed REIT to focus on investment in properties in the life science sector in the UK. The company will invest in may include wet and dry laboratories, offices, incubators and co-working spaces, manufacturing and testing facilities, and data centers.

Life Science REIT Headlines

No Headlines